← Oncology Approval Tracker

FDA DECISION ·

Opdivo

nivolumab · Bristol Myers Squibb

Traditional approvalTraditional conversionUrothelial carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Locally advanced or metastatic urothelial carcinoma progressing during or after platinum-containing chemotherapy, or within 12 months of perioperative platinum chemotherapy.

LAMPGEN ANALYSIS

Why it matters

This conversion concerns an established advanced disease indication and is separate from the same-day adjuvant approval.

What research teams should watch

Use the progression date and last platinum dose to classify the applicable prior-treatment interval.

PRIMARY RECORDS

Sources